Lmr Partners LLP Arvinas, Inc. Transaction History
Lmr Partners LLP
- $8.3 Billion
- Q1 2025
A detailed history of Lmr Partners LLP transactions in Arvinas, Inc. stock. As of the latest transaction made, Lmr Partners LLP holds 21,100 shares of ARVN stock, worth $141,159. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,100
Previous 100,000
78.9%
Holding current value
$141,159
Previous $1.92 Million
92.28%
% of portfolio
0.0%
Previous 0.02%
Shares
1 transactions
Others Institutions Holding ARVN
# of Institutions
246Shares Held
62.5MCall Options Held
2.65MPut Options Held
1.1M-
Vanguard Group Inc Valley Forge, PA8.36MShares$55.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.26MShares$41.9 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il3.88MShares$25.9 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.83MShares$25.6 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY3.33MShares$22.3 Million0.38% of portfolio
About ARVINAS, INC.
- Ticker ARVN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,205,300
- Market Cap $356M
- Description
- Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...